Proportion of Patients With Detected Antibodies in the ELEMENT 2 Trial
| Population | Visit | Basaglar Patients With Detected Antibodies (n [%]) | Lantus Patients With Detected Antibodies (n [%]) |
|---|---|---|---|
| Full analysis set | Baseline | 20 (5.5) | 13 (3.6) |
| Week 24 overall | 56 (15.3) | 40 (11.0) | |
| Week 24 LOCF | 30 (8.2) | 22(6.0) | |
| Previous Lantus patients | Baseline | 10 (6.6) | 6 (4.4) |
| Week 24 overall | 29 (19.2) | 11 (7.9) | |
| Week 24 LOCF | 13 (8.6) | 5 (3.6) | |
| Previously insulin-naive patients | Baseline | 10 (4.7) | 7 (3.1) |
| Week 24 overall | 27 (12.6) | 29 (12.8) | |
| Week 24 LOCF | 17 (7.9) | 17 (7.5) |